A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
Clinical trial NCT00724334 · COMPLETED
Trial details
- NCT number
- NCT00724334
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.